Metropolis Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2026, declared 2nd Interim Dividend of Re. 1 per equity share.
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare declared a 2nd Interim Dividend of Rs. 1 per equity share for FY2025-26, with record date May 19, 2026. The company reported strong FY2026 standalone revenue of Rs. 1,36,547 lakhs (up 12.3% YoY) and consolidated revenue of Rs. 1,64,585 lakhs (up 23.6% YoY). Standalone PAT grew 26.4% to Rs. 15,714 lakhs while consolidated PAT rose 31.4% to Rs. 19,118 lakhs. The Board approved appointment of Deloitte Haskins & Sells as new statutory auditors for 5 years, replacing B S R & Co. LLP. Additionally, Dr. Nilesh Shah transitioned from President - Internal Assurance to an advisory role effective May 14, 2026. Earlier in FY2026, the company had already paid a 1st interim dividend of Rs. 4 per share (pre-bonus) totaling Rs. 20.73 crore.
The dividend payout of Rs. 20.73 crore represents the same absolute amount as the 1st interim dividend due to the 3:1 bonus share issuance that increased share count from 5.18 crore to 20.73 crore. The strong financial results with 26-31% profit growth indicate solid operational performance, though the per-share dividend is modest at Rs. 1.